[Giant-cell vasculitis (arteritis and phlebitis)]

Arkhiv Patologii
|January 1, 1981
PubMed

Insights

Giant cell vasculitis can affect various blood vessels, not just the temporal artery. This study identifies potential triggers like xenobiotics, protozoa, bacteria, and viruses in vasculitis development.

Area of Science:

  • Vascular Medicine
  • Pathology
  • Immunology

Background:

  • Vasculitis encompasses a group of disorders characterized by inflammation of blood vessel walls.
  • Giant cell vasculitis is a specific subtype often associated with large arteries, but its presentation in other vessels is less understood.

Observation:

  • Five patients presented with vasculitis affecting diverse vessels including subcutaneous veins, cardiac and renal arteries, gallbladder artery, and spermatic cord veins.
  • Giant cells were observed within granulomatous reactions, predominantly near or within the intima of affected vessels.
  • Histopathological findings were noted in conditions such as endarteritis, periarteritis nodosa, and Buerger's disease.

Findings:

  • The study expands the known localizations of vasculitis beyond the temporal artery.
  • The presence of giant cells suggests an immune-mediated inflammatory process.
  • Specific nosological forms like endarteritis and periarteritis nodosa were associated with giant cell formation.

Implications:

  • This research highlights the varied clinical presentations of giant cell vasculitis.
  • It proposes a hypothesis for the etiology involving external agents like chemical haptens, protozoa, bacteria, or viruses.
  • Further investigation into these potential etiological factors could lead to novel diagnostic and therapeutic strategies for vasculitis.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Acute Inflammation II: Cellular Phase01:26

Acute Inflammation II: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...